What time did they release the results on July 22 or 23 , 2025 that pushed the abvx stock price up 600 percent and what app or news source released the story first

The positive results for Abivax's obefazimod in the Phase 3 induction trials for ulcerative colitis were released on July 22, 2025. The stock price of ABVX increased significantly, reportedly jumping more than 500% on July 23, 2025, following the announcement. The first news source to release the story was Investing.com, which reported on the positive Phase 3 results for Abivax's ulcerative colitis drug on July 22, 2025. The company's official announcement was released through EQS-News on the same day. Subsequently, various other news outlets and financial platforms covered the story, contributing to the widespread dissemination of the positive results.